{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:07:33Z","timestamp":1767989253021,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sytheon Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02514-0","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T15:02:41Z","timestamp":1670770961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"nct04345094","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hera","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence A.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas A.","family":"Burney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy J.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianne","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7205-8162","authenticated-orcid":false,"given":"Raja K.","family":"Sivamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,11]]},"reference":[{"key":"2514_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/9781444317657.ch2","volume-title":"In cosmetic dermatology","author":"M Alam","year":"2010","unstructured":"Alam M, Havey J (2010) Photoaging. In: Draelos ZD (ed) In cosmetic dermatology. Wiley-Blackwell, Oxford, pp 13\u201321"},{"key":"2514_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20200207","volume":"6","author":"D Raikar","year":"2020","unstructured":"Raikar D, Javed MD, Takalkar AA (2020) A clinical and epidemiological study of hyperpigmentary disorder of face. Int J Res Dermatol 6:183\u2013186. https:\/\/doi.org\/10.18203\/issn.2455-4529.IntJResDermatol20200207","journal-title":"Int J Res Dermatol"},{"key":"2514_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/idoj.IDOJ_209_19","volume":"11","author":"L Raveendra","year":"2020","unstructured":"Raveendra L, Sidappa H, Shree S (2020) A study of quality of life in patients with facial melanoses. Indian Dermatol Online J 11:154\u2013157. https:\/\/doi.org\/10.4103\/idoj.IDOJ_209_19","journal-title":"Indian Dermatol Online J"},{"key":"2514_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40257-016-0239-8","volume":"18","author":"NA Vashi","year":"2017","unstructured":"Vashi NA, Wirya SA, Inyang M, Kundu RV (2017) Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol 18:215\u2013230. https:\/\/doi.org\/10.1007\/s40257-016-0239-8","journal-title":"Am J Clin Dermatol"},{"key":"2514_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","volume":"62","author":"K Jimbow","year":"1974","unstructured":"Jimbow K, Obata H, Pathak MA, Fitzpatrick TB (1974) Mechanism of depigmentation by hydroquinone. J Invest Dermatol 62:436\u2013449. https:\/\/doi.org\/10.1111\/1523-1747.ep12701679","journal-title":"J Invest Dermatol"},{"key":"2514_CR6","first-page":"1","volume":"366","author":"P National Toxicology","year":"1989","unstructured":"National Toxicology P (1989) NTP toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9) in F344\/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 366:1\u2013248","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"key":"2514_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/009841098158863","volume":"54","author":"RC Wester","year":"1998","unstructured":"Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D, Maibach HI (1998) Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition. J Toxicol Environ Health A 54:301\u2013317. https:\/\/doi.org\/10.1080\/009841098158863","journal-title":"J Toxicol Environ Health A"},{"key":"2514_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1473-2165.2005.40202.x","volume":"4","author":"W Westerhof","year":"2005","unstructured":"Westerhof W, Kooyers TJ (2005) Hydroquinone and its analogues in dermatology - a potential health risk. J Cosmet Dermatol 4:55\u201359. https:\/\/doi.org\/10.1111\/j.1473-2165.2005.40202.x","journal-title":"J Cosmet Dermatol"},{"issue":"Suppl 6","key":"2514_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1289\/ehp.961041339","volume":"104","author":"SN Yin","year":"1996","unstructured":"Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Zhang ZN, Li DG, Chow WH, Wacholder S et al (1996) An expanded cohort study of cancer among benzene-exposed workers in China Benzene Study Group. Environ Health Perspect 104(Suppl 6):1339\u20131341. https:\/\/doi.org\/10.1289\/ehp.961041339","journal-title":"Environ Health Perspect"},{"key":"2514_CR10","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 785, Hydroquinone. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Hydroquinone. Accessed 10 Dec 2022"},{"key":"2514_CR11","unstructured":"Chaudhuri R (2015) Hexylresorcinol Providing Skin Benefits by Modulating Multiple Molecular Targets. In: Raja K Sivamani, Jared Jagdeo PE, Howard I Maibach (eds) Cosmeceuticals and Active Cosmetics, CRC Press, Boca Raton, pp 71\u201381."},{"key":"2514_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1753-4887.2004.tb00029.x","volume":"62","author":"AB Ross","year":"2004","unstructured":"Ross AB, Kamal-Eldin A, Aman P (2004) Dietary alkylresorcinols: absorption, bioactivities, and possible use as biomarkers of whole-grain wheat- and rye-rich foods. Nutr Rev 62:81\u201395. https:\/\/doi.org\/10.1111\/j.1753-4887.2004.tb00029.x","journal-title":"Nutr Rev"},{"key":"2514_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/jf980712x","volume":"47","author":"JG Buta","year":"1999","unstructured":"Buta JG, Moline HE, Spaulding DW, Wang CY (1999) Extending storage life of fresh-cut apples using natural products and their derivatives. J Agric Food Chem 47:1\u20136. https:\/\/doi.org\/10.1021\/jf980712x","journal-title":"J Agric Food Chem"},{"key":"2514_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1902\/jop.1977.48.3.156","volume":"48","author":"RT Evans","year":"1977","unstructured":"Evans RT, Baker PJ, Coburn RA, Fischman SL, Genco RJ (1977) In vitro antiplaque effects of antiseptic phenols. J Periodontol 48:156\u2013162. https:\/\/doi.org\/10.1902\/jop.1977.48.3.156","journal-title":"J Periodontol"},{"key":"2514_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-5347(17)73434-9","volume":"15","author":"V Leonard","year":"1926","unstructured":"Leonard V, Frobisher M (1926) Clinical application of hexylresorcinol in urology with observations on the significance of surface tension in urinary antisepsis1. J Urol 15:1\u201310. https:\/\/doi.org\/10.1016\/S0022-5347(17)73434-9","journal-title":"J Urol"},{"key":"2514_CR16","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.3390\/app10103385","volume":"10","author":"J-Y Kim","year":"2020","unstructured":"Kim J-Y, Seok H (2020) Role of 4-hexylresorcinol in the field of tissue engineering. Appl Sci 10:3385. https:\/\/doi.org\/10.3390\/app10103385","journal-title":"Appl Sci"},{"key":"2514_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00403-014-1439-9","volume":"306","author":"YK Won","year":"2014","unstructured":"Won YK, Loy CJ, Randhawa M, Southall MD (2014) Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation. Arch Dermatol Res 306:455\u2013465. https:\/\/doi.org\/10.1007\/s00403-014-1439-9","journal-title":"Arch Dermatol Res"},{"key":"2514_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ics.12759","volume":"44","author":"R Shariff","year":"2022","unstructured":"Shariff R, Du Y, Dutta M, Kumar ST, Thimmaiah S, Doraiswamy C, Kumari A, Kale V, Nair N, Zhang S et al (2022) Superior even skin tone and anti-ageing benefit of a combination of 4-hexylresorcinol and niacinamide. Int J Cosmet Sci 44:103\u2013117. https:\/\/doi.org\/10.1111\/ics.12759","journal-title":"Int J Cosmet Sci"},{"key":"2514_CR19","first-page":"863","volume":"15","author":"P Farris","year":"2016","unstructured":"Farris P, Zeichner J, Berson D (2016) Efficacy and tolerability of a skin brightening\/anti-aging cosmeceutical containing retinol 0.5%, niacinamide, hexylresorcinol, and resveratrol. J Drugs Dermatol 15:863\u2013868","journal-title":"J Drugs Dermatol"},{"key":"2514_CR20","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 3610, Hexylresorcinol. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Hexylresorcinol. Accessed 10 Dec 2022"},{"key":"2514_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0273-2300(91)90007-i","volume":"14","author":"VH Frankos","year":"1991","unstructured":"Frankos VH, Schmitt DF, Haws LC, McEvily AJ, Iyengar R, Miller SA, Munro IC, Clydesdale FM, Forbes AL, Sauer RM (1991) Generally recognized as safe (GRAS) evaluation of 4-hexylresorcinol for use as a processing aid for prevention of melanosis in shrimp. Regul Toxicol Pharmacol 14:202\u2013212. https:\/\/doi.org\/10.1016\/0273-2300(91)90007-i","journal-title":"Regul Toxicol Pharmacol"},{"key":"2514_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13104-020-04954-1","volume":"13","author":"D Matthews","year":"2020","unstructured":"Matthews D, Adegoke O, Shephard A (2020) Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat. BMC Res Notes 13:99. https:\/\/doi.org\/10.1186\/s13104-020-04954-1","journal-title":"BMC Res Notes"},{"key":"2514_CR23","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/app10051737","volume":"10","author":"Y-J Kang","year":"2020","unstructured":"Kang Y-J, Oh J-H, Seok H, Jo Y-Y, Kim D-W, Garagiola U, Choi J-Y, Kim S-G (2020) 4-hexylresorcinol exhibits different characteristics to estrogen. Appl Sci 10:1737. https:\/\/doi.org\/10.3390\/app10051737","journal-title":"Appl Sci"},{"key":"2514_CR24","doi-asserted-by":"publisher","DOI":"10.35248\/2167-7956.19.8.170","author":"J Fidalgo","year":"2019","unstructured":"Fidalgo J, Deglesne PA, Arroya R, Ranneva E, Deprez P (2019) 4-hexylresorcinol a new molecule for cosmetic application. J Biomol Res Ther. https:\/\/doi.org\/10.35248\/2167-7956.19.8.170","journal-title":"J Biomol Res Ther"},{"key":"2514_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/bjd.13747","volume":"173","author":"S Kaur","year":"2015","unstructured":"Kaur S, Kizoulis M, Fantasia J, Oddos T, Bigot N, Galera P, Tucker-Samaras S, Leyden JJ, Southall MD (2015) 4-Hexyl-1,3-phenylenediol, a nuclear factor-kappaB inhibitor, improves photodamaged skin and clinical signs of ageing in a double-blinded, randomized controlled trial. Br J Dermatol 173:218\u2013226. https:\/\/doi.org\/10.1111\/bjd.13747","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02514-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T19:03:49Z","timestamp":1671044629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02514-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,11]]},"references-count":25,"alternative-id":["2514"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02514-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,11]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RKS serves as a scientific advisor for LearnHealth, Codex Beauty, and Arbonne and has received honoraria from Burts Bees, Regeneron, Nutrafol, Sanofi, Galderma, Fotona, Incyte, Novozymes, Novartis, Leo, UCB, Sun Pharma, and Abbvie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval #HHSOL-1495\u2013125.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB IntegReview has approved the study"}}]}}